“Comparison of Clinical Effectiveness of Folfirinox versus Gemcitabine on Quality of Life in Patients with Pancreatic Cancer Stage IV”, AJP, vol. 11, no. 03, Oct. 2017, doi: 10.22377/ajp.v11i03.1468.